Forest buys Cerexa for $494mm plus potential earnout

27 Oct 2020

Forest Laboratories has agreed to acquire antibiotics firm Cerexa for $493.6mm plus a potential earnout of $100mm.

Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash for Equity

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Forest buys Cerexa for $494mm plus potential earnout

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice